OTCMKTS:BIOQ

Bioqual Stock Forecast, Price & News

$87.00
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$87.00
Now: $87.00
$87.00
50-Day Range
$85.00
MA: $86.77
$88.00
52-Week Range
$50.00
Now: $87.00
$92.00
VolumeN/A
Average Volume383 shs
Market Capitalization$77.43 million
P/E Ratio16.60
Dividend Yield1.26%
Beta-0.33
Bioqual, Inc. provides research, development, pre-clinical, and testing/assay services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model services related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BIOQ
CUSIP09065J101
Phone240-404-7654
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.36 million
Cash Flow$4.39 per share
Book Value$27.46 per share

Profitability

Net Income$4.23 million

Miscellaneous

Market Cap$77.43 million
Next Earnings Date4/20/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.94 out of 5 stars

Medical Sector

1116th out of 2,021 stocks

Commercial Physical Research Industry

19th out of 42 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -
$87.00
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bioqual (OTCMKTS:BIOQ) Frequently Asked Questions

What stocks does MarketBeat like better than Bioqual?

Wall Street analysts have given Bioqual a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Bioqual wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Bioqual?

Bioqual saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 200 shares, an increase of 100.0% from the February 28th total of 100 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is presently 0.5 days.
View Bioqual's Short Interest
.

When is Bioqual's next earnings date?

Bioqual is scheduled to release its next quarterly earnings announcement on Tuesday, April 20th 2021.
View our earnings forecast for Bioqual
.

How were Bioqual's earnings last quarter?

Bioqual, Inc. (OTCMKTS:BIOQ) issued its quarterly earnings results on Friday, January, 22nd. The company reported $1.63 earnings per share (EPS) for the quarter. The business had revenue of $13.57 million for the quarter. Bioqual had a net margin of 9.12% and a trailing twelve-month return on equity of 17.62%.
View Bioqual's earnings history
.

How has Bioqual's stock price been impacted by COVID-19?

Bioqual's stock was trading at $51.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BIOQ stock has increased by 68.1% and is now trading at $87.00.
View which stocks have been most impacted by COVID-19
.

How often does Bioqual pay dividends? What is the dividend yield for Bioqual?

Bioqual declared an annual dividend on Tuesday, September 15th. Investors of record on Monday, September 28th will be paid a dividend of $1.10 per share on Wednesday, October 21st. This represents a dividend yield of 1.62%. The ex-dividend date is Friday, September 25th. This is a boost from Bioqual's previous annual dividend of $0.70.
View Bioqual's dividend history
.

Is Bioqual a good dividend stock?

Bioqual pays an annual dividend of $1.10 per share and currently has a dividend yield of 1.26%.
View Bioqual's dividend history.

Who are Bioqual's key executives?

Bioqual's management team includes the following people:
  • Dr. David A. Newcomer, Chief Financial Officer (Age 60, Pay $123.78k)
  • Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 56, Pay $103k)
  • Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 66)
  • Mitch Franklin, Chief Operating Officer
  • Nancy A. Madden, VP of Admin. Operations & Biosafety Officer
  • Dr. J. Thomas August, Consultant, Scientific Adviser and Director (Age 93)

Who are some of Bioqual's key competitors?

What is Bioqual's stock symbol?

Bioqual trades on the OTCMKTS under the ticker symbol "BIOQ."

How do I buy shares of Bioqual?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bioqual's stock price today?

One share of BIOQ stock can currently be purchased for approximately $87.00.

How much money does Bioqual make?

Bioqual has a market capitalization of $77.43 million and generates $46.36 million in revenue each year.

What is Bioqual's official website?

The official website for Bioqual is www.bioqual.com.

Where are Bioqual's headquarters?

Bioqual is headquartered at 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850.

How can I contact Bioqual?

Bioqual's mailing address is 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850. The company can be reached via phone at 240-404-7654 or via email at [email protected]


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.